Market revenue in 2023 | USD 164.2 million |
Market revenue in 2030 | USD 125.8 million |
Growth rate | -3.7% (CAGR from 2023 to 2030) |
Largest segment | Outpatient facilities |
Fastest growing segment | Home Care |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hospitals, Outpatient Facilities, Home Care |
Key market players worldwide | Becton Dickinson & Co, BioMerieux SA, Bio-Rad Laboratories Inc, Abbott Laboratories, Agilent Technologies Inc, Danaher Corp, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Roche Holding AG, Siemens Healthineers AG ADR, Sysmex Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular diagnostics market will help companies and investors design strategic landscapes.
Outpatient facilities was the largest segment with a revenue share of 47.08% in 2023. Horizon Databook has segmented the UAE molecular diagnostics market based on hospitals, outpatient facilities, home care covering the revenue growth of each sub-segment from 2018 to 2030.
Amid the pandemic in UAE, numerous government and private organizations mandated the RT-PCR testing report, leading to a remarkably high testing rate. In addition, home testing services were also introduced in the country for higher adoption of tests. The rise in initiatives undertaken by public and private players is expected to propel market growth.
For instance, Thumbay Labs launched COVID-19 testing for people across UAE. In addition, InterSystems signed an agreement with Pure Health to distribute the InterSystems TrakCare Lab Enterprise system to support COVID-19 testing initiatives in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into UAE molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account